Levetiracetam Eg Stada (Levetiracetam)

• Levetiracetam is an antiepileptic medication that controls seizure activity across several epilepsy syndromes.
• Partial seizures: reduces the frequency of focal onset seizures in patients with epilepsy.
• Generalized tonic‑clonic seizures: helps prevent convulsive episodes in generalized epilepsy.
• Myoclonic seizures: decreases the occurrence of rapid, shock‑like muscle jerks associated with myoclonic epilepsy.

• Levetiracetam binds to the synaptic vesicle protein SV2A, modulating neurotransmitter release and stabilizing neuronal membranes. This action reduces abnormal neuronal firing and excitability, thereby diminishing the propagation of seizure activity throughout the central nervous system.

Levetiracetam may cause a range of adverse reactions, varying in frequency and severity.

Common Side Effects

• Dizziness: sensation of light‑headedness or imbalance.
• Somnolence: increased sleepiness or fatigue.
• Headache: mild to moderate cranial discomfort.
• Irritability: mood changes including agitation.
• Nausea: upset stomach or feeling of queasiness.
• Fatigue: reduced energy levels.

Serious or Rare Side Effects

• Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Mood alterations: including depression, suicidal thoughts, or aggressive behavior.
• Hematologic abnormalities: rare cases of blood dyscrasias.
• Multi‑organ hypersensitivity: systemic allergic response affecting multiple organs.

• When prescribing or dispensing levetiracetam, several safety considerations should be observed.
• Renal impairment: adjust dose in patients with reduced kidney function.
• Pregnancy Category B: weigh benefits against potential risks before use.
• Behavioral monitoring: observe for mood changes or suicidal ideation.
• Discontinuation: avoid abrupt cessation to prevent seizure recurrence.
• Drug interactions: review concomitant medications for potential effects on levetiracetam levels.
• Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Levetiracetam has a relatively low interaction profile, but certain drugs can affect its plasma concentrations or efficacy.

Major Interactions (Avoid)

• Carbamazepine: induces metabolism, lowering levetiracetam levels.
• Phenobarbital: increases clearance, reducing therapeutic effect.
• Phenytoin: may decrease levetiracetam concentrations.
• Rifampin: induces hepatic enzymes, diminishing drug exposure.
• St. John’s wort: herbal inducer that can lower levetiracetam levels.

Moderate Interactions (Monitor Closely)

• Valproic acid: may increase levetiracetam concentrations.
• Other antiepileptics (e.g., lamotrigine): monitor for additive CNS effects.
• Alcohol: can enhance sedation and dizziness.
• CNS depressants: watch for increased drowsiness.
• Oral contraceptives: monitor efficacy, though interaction is minimal.